Bio-rad Laboratories Stock News

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $752.95 and last traded at $752.95, with a volume of 7 shares. The stock had previously closed at $752.95. The firm has a market cap of $22.53 billion, a P/E ratio of 45.72 and []

Bio-Rad Laboratories, Inc. (NYSE:BIO) EVP Annette Tumolo sold 1,546 shares of Bio-Rad Laboratories stock in a transaction dated Thursday, November 11th. The shares were sold at an average price of $749.00, for a total value of $1,157,954.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this []

Biotest Aktiengesellschaft (ETR:BIO)s share price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as 44.00 ($51.76) and last traded at 43.70 ($51.41), with a volume of 2525 shares traded. The stock had previously closed at 43.30 ($50.94). The company has a debt-to-equity ratio of 122.54, a quick []

The Latest survey report on Global Point-of-Care or Rapid Testing Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Point-of-Care or Rapid Testing organizations have the dual challenge of increasing

Bio-Rad Laboratories (NYSE: BIO.B) is one of 42 publicly-traded companies in the Analytical instruments industry, but how does it weigh in compared to its peers? We will compare Bio-Rad Laboratories to related businesses based on the strength of its valuation, profitability, dividends, institutional ownership, analyst recommendations, risk and earnings. Analyst Ratings This is a summary []

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)s share price reached a new 52-week high on Tuesday . The company traded as high as $752.95 and last traded at $752.95, with a volume of 7 shares trading hands. The stock had previously closed at $752.95. The firm has a market cap of $22.53 billion, a P/E ratio of 3.42 []

Related Stocks: IWM , MSFT , FIS , ROST , DHHCU , VTWO , NGMS , OPEN , FRSH , FRSH , DALS , WIX , ATUS , BIO , MARA , CELC , GOAC.U ,

Bio-Rad Laboratories, Inc. (NYSE:BIO) EVP Annette Tumolo sold 1,546 shares of the companys stock in a transaction dated Thursday, November 11th. The stock was sold at an average price of $749.00, for a total transaction of $1,157,954.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through []

Key Companies Covered in the Liquid Biopsy Market Research Report Are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Illumina, Inc., Inivata Limited, Agena Bioscience, Inc., Thermo Fisher Scientific, Guardant Health, Inc., and other key market players. Key Companies Covered in the Liquid Biopsy Market Research Report Are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Illumina, Inc., Inivata Limited, Agena Bioscience, Inc., Thermo Fisher Scientific, Guardant Health, Inc., and other key market players.

Bio-Rad Laboratories (NYSE: BIO.B) is one of 42 public companies in the Analytical instruments industry, but how does it contrast to its rivals? We will compare Bio-Rad Laboratories to related companies based on the strength of its earnings, risk, valuation, institutional ownership, dividends, profitability and analyst recommendations. Profitability This table compares Bio-Rad Laboratories and its []

Bio-Rad Laboratories (NYSE: BIO.B) is one of 42 public companies in the Analytical instruments industry, but how does it weigh in compared to its competitors? We will compare Bio-Rad Laboratories to similar businesses based on the strength of its dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability. Analyst Recommendations This is a breakdown []

Strength in the Life Science and Clinical Diagnostics segments drove Bio-Rad's (BIO) revenues in the third quarter.

Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2021 Results - Earnings Call Transcript

Beating the market is hard, but it can be made easier by using the right set of tools. Here are the metrics to analyze penny stocks.

We believe that there are other stocks that are currently better valued than eBay's stock. EBAY's current price-to-operating income ratio (P/EBIT) of 16.7x is higher than levels of 13.3x for PerkinElm